Physician

Stephen J. Phillips, M.D.

According to 2025 Medicare claims, Stephen Phillips, M.D. (NPI: 1265499693) practices ophthalmology in the Myrtle Beach-Conway-North Myrtle Beach, SC market, with the plurality of this provider's patient population coming from Horry, SC. This provider's primary affiliated billing organization is CHARLESTON NEUROSCIENCES INSTITUTE (NPI: 1225094600; TIN: 202359956) and primary practice location at 29588-4504.

Phillips' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,007 traditional Medicare patients, billed 42,731 HCPCS/CPT codes, and received $5,032,466 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 206 prescription claims across 75 beneficiaries totaling $15,299 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 5 records totaling $94. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $979,769 to $5,032,466. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.5M$5.1M2015 Medicare payment: $979,769 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,195,807 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,286,806 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,392,947 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,426,184 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $4,662,349 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $5,090,064 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $5,050,332 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $5,070,109 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $5,032,466 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,01210,602$979,769
20161,01111,611$1,195,807
20171,05212,141$1,286,806
20181,06612,041$1,392,947
20191,04014,181$2,426,184
202092217,541$4,662,349
202196717,919$5,090,064
202293820,755$5,050,332
202393946,110$5,070,109
20241,00742,731$5,032,466

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$16K$32K2015 Drug cost: $32,249 (USD; Tot_Drug_Cst)2016 Drug cost: $11,025 (USD; Tot_Drug_Cst)2017 Drug cost: $13,996 (USD; Tot_Drug_Cst)2018 Drug cost: $16,477 (USD; Tot_Drug_Cst)2019 Drug cost: $15,222 (USD; Tot_Drug_Cst)2020 Drug cost: $15,230 (USD; Tot_Drug_Cst)2021 Drug cost: $13,469 (USD; Tot_Drug_Cst)2022 Drug cost: $11,118 (USD; Tot_Drug_Cst)2023 Drug cost: $11,620 (USD; Tot_Drug_Cst)2024 Drug cost: $15,299 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201559168$32,249
201652133$11,025
201769205$13,996
201879221$16,477
201966179$15,222
202066219$15,230
202182240$13,469
202277221$11,118
202385238$11,620
202475206$15,299

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg3784,025$647
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more187187$110
67028Injection of drug into eye6723,159$92
92134Imaging of retina8383,313$32
92250Photography of the retina197313$28

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate702,450$3,904
Atropine SulfateAtropine Sulfate451,144$1,433
MoxifloxacinMoxifloxacin Hcl34400$646
GatifloxacinGatifloxacin18179$581
LatanoprostLatanoprost19851$61

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.5$94Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Stephen J. Phillips, M.D.?

Tedicare shows public-source Medicare data for Stephen J. Phillips, M.D. (NPI 1265499693), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Stephen J. Phillips, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Stephen J. Phillips, M.D.?

Stephen J. Phillips, M.D. is linked to CHARLESTON NEUROSCIENCES INSTITUTE (billing NPI 1225094600) in the available physician profile data.

Does Stephen J. Phillips, M.D. have Open Payments data?

Stephen J. Phillips, M.D. has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.